Biocytogen

Exhibitor

Biocytogen is a global biotech company that drives the discovery of fully human monoclonal,

bispecific, multispecific, ADC, VHH, and TCR-mimic antibodies across 1,000+ druggable

targets, providing 1M+ authentic antibody sequences through its RenBiologics™ sub-brand for

partnerships.

Biocytogen is advancing antibody drug development through innovative technologies.

Leveraging gene-editing expertise, it pioneered drug target knock-in humanized models and

offers 4,000+ models via BioMice™

, along with in vivo, ex vivo, and in vitro pharmacology and

custom gene-editing services.